v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (17,740,000) $ (10,653,000)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 56,000 31,000
Share-based compensation 407,000 201,000
Change in fair value of convertible notes payable 728,000 0
Change in fair value of warrant liabilities 16,000 265,000
Amortization of debt discount and debt issuance costs 127,000 9,000
Changes in operating assets and liabilities    
Accounts receivable (419,000) 409,000
Inventory (593,000) (486,000)
Other assets (139,000) (104,000)
Accounts payable 727,000 1,521,000
Accrued liabilities and other (898,000) (916,000)
Net cash used in operating activities (17,728,000) (9,723,000)
Cash flows from investing activities    
Purchases of property and equipment (42,000) (23,000)
Net cash used in investing activities (42,000) (23,000)
Cash flows from financing activities    
Exercise of common stock options 358,000 211,000
Proceeds from issuance of convertible notes payable 14,102,000 0
Proceeds from the related party issuance of convertible notes payable 25,898,000 0
Proceeds from issuance of Series F redeemable convertible preferred stock, net of issuance costs 0 29,611,000
Proceeds from the related party issuance of Series F redeemable convertible preferred stock, net of issuance costs 0 2,602,000
Payment of deferred offering costs (450,000) 0
Net cash provided by financing activities 39,908,000 32,424,000
Net change in cash and cash equivalents 22,138,000 22,678,000
Cash and cash equivalents, beginning of period 33,587,000 14,620,000
Cash and cash equivalents, end of period 55,725,000 37,298,000
Supplemental disclosures of cash flows information    
Cash paid for interest $ 230,000 $ 230,000